Result: Risk Minimisation Materials for medicines starting with the letter E

Elidel

Meda Pharmaceuticals

Important information on the appropriate use of Elidel

Important information on the appropriate use of ELIDEL® (pimecrolimus cream 10 mg/g)

For Healthcare Professionals

Eliquis

Bristol-Myers Squibb-Pfizer

Eliquis (apixaban) Patient Alert Card

This risk minimisation material has been developed for Eliquis for all indications. Patients prescribed Eliquis will receive a Patient Alert Card in the medication pack with the package leaflet. Please ensure that you are familiar with this material as it contains important safety information. In particular, it is aimed at increasing awareness about the potential risk of bleeding during treatment with Eliquis and providing guidance on how to manage that risk. As the card contains important information, the patient should be instructed to carry the Patient Alert Card at all times and show it to every healthcare professional including pharmacists. If you would like a hard copy of the Eliquis Prescriber Guide and/or Patient Alert Card and/or SmPC (5mg and 2.5mg) posted out to you, please contact BMS Medical Information (telephone: 0800 731 1736; e-mail: medical.information@bms.com). Please note that risk minimisation materials can only be delivered to UK registered healthcare premises.

Eliquis (apixaban) Prescriber Guide

This risk minimisation material has been developed for Eliquis for all indications. Please ensure that you are familiar with this material before prescribing Eliquis as it contains important safety information. In particular, it is aimed at increasing awareness about the potential risk of bleeding during treatment with Eliquis and providing guidance on how to manage that risk. If you would like a hard copy of the Eliquis Prescriber Guide and/or Patient Alert Cards and/or Summary of Product Characteristics (5mg and 2.5mg) posted out to you, please contact Bristol-Myers Squibb Medical Information (telephone: 0800 731 1736; e-mail: medical.information@bms.com) with your specific request. Please note that risk minimisation materials can only be delivered to UK registered healthcare premises.

For Healthcare Professionals

Ellaone

HRA Pharma UK and Ireland Limited

ellaOne letter to healthcare professionals

Post-marketing surveillance and pregnancy registry

For Healthcare Professionals

ELOINE

Bayer plc

CHCs ANNEX 1_Direct HCP Communication

Direct Healthcare Professional Communication, to inform of the results of a Europe-wide review and the latest evidence on the risk of thromboembolism in association with certain combined hormonal contraceptives (CHCs).

For Healthcare Professionals

CHCs ANNEX 2_Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers.

For Healthcare Professionals

CHCs ANNEX 3_Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

CHCs ANNEX 4_CHCs Important Info for Women

Combined hormonal contraceptives: important information for women.

Emerade

Bausch & Lomb U.K Limited

Emerade Expiry Reminder

Expiry Reminder for Emerade, 150 micrograms; 300 micrograms; 500 micrograms, solution for injection in pre-filled pen.

How to use Emerade instruction video

Demonstration video for Emerade, 150 micrograms; 300 micrograms; 500 micrograms, solution for injection in pre-filled pen.

Enbrel

Pfizer Limited

Enbrel MyClic HCP Flip Chart

Flip chart with step by step guide to using Enbrel 25mg & 50mg pre-filled pen - MyClic

For Healthcare Professionals

Enbrel Patient Injection Instruction Guide

Patient Injection Instruction Guide

Entyvio

Takeda UK Ltd

Entyvio (vedolizumab) HCP Educational Brochure

Information leaflet for HCPs Administering Entyvio

For Healthcare Professionals

Entyvio (vedolizumab) Patient Alert Card

To be provided to patients receiving treatment with Entyvio by a HCP

Envarsus

Chiesi Limited

Envarsus – prolonged-release tacrolimus tablets

Educational materials for the healthcare professional (doctor or pharmacist) Please read the full Summary of Product Characteristics before prescribing Envarsus

For Healthcare Professionals

Envarsus Patient Card

Envarsus Prolonged-release tacrolimus tablets Patient Card

For Healthcare Professionals

Epilim

SANOFI

Valproate- Checklist HCP – Risks in Female patients

Checklist for prescribers related to Valproate use in female patients. For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Valproate- HCP Booklet – Risks in Female patients

Healthcare professional risk minimisation booklet for Valproate in female patients. For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Valproate- Letter for Pharmacists- HCP- Risks in Female patients

Communication letter to pharmacists explaining risk minimisation materials for managing patients taking Valproate based medicines

For Healthcare Professionals

Valproate- Letter for Prescribers -Risks in Female patients

For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Valproate- Letter for Primary Care HCP -Risks in Female patients

Communication letter to HCP's providing primary care, obstetric or family planning services to female patients taking Valproate containing medicines.

For Healthcare Professionals

Valproate- Letter for Specialists – Risks in Female patients

Communication letter explaining risk minimisation materials for specialists managing patients taking Valproate based medicines. For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Valproate- Patient Card – Risks in Female patients

Risk minimization Patient card for Valproate in female patients. For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com

Valproate- Patient Guide – Risks in Female patients

Patient Guide risk minimisation booklet for Valproate in female patients. For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

Valproate- Poster- Dispensary- Risks in Female patients

FOR DISPENSARY USE ONLY For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Valproate- Safety Card- HCP- Risks in Female patients

For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com

For Healthcare Professionals

Valproate- Shelf Barker- HCP- Risks in Female patients

For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com

For Healthcare Professionals

EpiPen

Meda Pharmaceuticals

EpiPen® Demonstration Video

Demonstration video showing patients the correct usage of the EpiPen®

EpiPen® Expiry Alert Service

If your EpiPen® is out of date, you must replace it immediately

Episenta

Desitin Pharma Ltd

Checklist - valproate use in female patients

Checklist for prescribers related to valproate use in female patients

For Healthcare Professionals

HCP Booklet - valproate use in female patients

Healthcare professional risk minimisation booklet for valproate in female patients

For Healthcare Professionals

Patient Card - valproate use in female patients

Risk minimisation Patient Card for valproate in female patients

Patient Guide - valproate use in female patients

Risk minimisation Patient Guide booklet for valproate in female patients

Erelzi

Sandoz Limited

Erelzi (Etanercept) Patient Alert Card

The patient alert card contains information on the following for patients treated with Erelzi: - Use in children and adolescents - Opportunistic infections and tuberculosis (TB) - Congestive Heart Failure (CHF).

Erivedge

Roche Products Limited

Erivedge (vismodegib) HCP Reminder Card

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Erivedge (vismodegib) Patient Reminder Card

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

Erivedge (vismodegib) Pregnancy Prevention Programme HCP Brochure

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Erivedge (vismodegib) Pregnancy Prevention Programme HCP Verification of Counselling Form

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Erivedge (vismodegib) Pregnancy Prevention Programme Patient Booklet

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

Erivedge Pharmacist Dispensing Checklist

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Erivedge Pharmacists CoR Form

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Erivedge Prescriber Confirmation Role

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

Esbriet

Roche Products Limited

Esbriet (pirfenidone) Safety Checklist for Prescribing Physicians

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan

For Healthcare Professionals

Esmya

Gedeon Richter (UK) Ltd

Pathologist' Guide - Esmya

Guide for pathologists dealing with gynaecological tissue which may have been exposed to Esmya (Ulipristal acetate)

For Healthcare Professionals

Physician's Guide to Prescribing - Esmya

Educational material for prescribers

For Healthcare Professionals

Evra

Janssen-Cilag Ltd

Annex 2 Checklist for Prescribers

Checklist for prescribers to guide them on discussion with patients on risk factors associated with Combined hormonal contracpetives and thromboembolism

For Healthcare Professionals

Annex 3 Important Information for Women

Document summarises important risk factors of a blood clot and advises on action to be taken if certain symptoms are experienced

Annex 4 leaflet for women

Leaflet with information on combined oral contraception to be given to patient by the physician

Exjade

Novartis Pharmaceuticals UK Ltd

Exjade (deferasirox): Important information about your treatment and possible side effects.

Please keep this document safe for future reference. This booklet is only intended for patients that have been prescribed deferasirox. It contains important information, including how to take deferasirox the right way, why monitoring your treatment is important, and which medicines you can take while on deferasirox.

Important Information to Remember About Exjade (deferasirox) Treatment.

This booklet provides detailed information on posology and monitoring of patients on deferasirox, to minimise key adverse effects including medication errors during treatment.

For Healthcare Professionals

Eylea

Bayer plc

EYLEA BRVO Patient Guide

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO)

EYLEA CNV Patient Guide

Your guide to Eylea - for the treatment of visual impairment due to myopic choroidal neovascularisation (myopic CNV)

EYLEA CRVO Patient Guide

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO)

EYLEA DMO Patient Guide

Your guide to Eylea - for the treatment of visual impairment due to diabetic macular oedema (DMO)

Eylea Prescriber Guide

Prescriber guide to intravitreal injections with Eylea.

For Healthcare Professionals

EYLEA WAMD Patient Guide

Your guide to Eylea - for the treatment of neovascular (wet) age-related macular degeneration (AMD).